These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34547589)

  • 1. Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia.
    Paquette M; Bernard S; Baass A
    Atherosclerosis; 2021 Oct; 335():41-46. PubMed ID: 34547589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia.
    Fantino M; Paquette M; Bernard S; Baass A
    J Clin Lipidol; 2021; 15(4):602-607. PubMed ID: 34130940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    J Clin Lipidol; 2023; 17(3):376-383. PubMed ID: 37003850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
    Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
    Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia and cardiovascular disease in older individuals.
    Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
    Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
    Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events.
    Tada H; Okada H; Nomura A; Nohara A; Yamagishi M; Takamura M; Kawashiri MA
    J Clin Lipidol; 2021; 15(2):358-365. PubMed ID: 33461934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia.
    Paquette M; Fantino M; Bernard S; Baass A
    Atherosclerosis; 2021 Jul; 329():9-13. PubMed ID: 34157652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study.
    Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
    Eur J Clin Invest; 2024 Feb; 54(2):e14119. PubMed ID: 37916502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
    Paquette M; Cariou B; Bernard S; Hegele RA; Gallo A; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):505-512. PubMed ID: 38031840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
    de Isla LP; Vallejo-Vaz AJ; Watts GF; Muñiz-Grijalvo O; Alonso R; Diaz-Diaz JL; Arroyo-Olivares R; Aguado R; Argueso R; Mauri M; Romero MJ; Álvarez-Baños P; Mañas D; Cepeda JM; Gonzalez-Bustos P; Casañas M; Michan A; Muñoz-Torrero JFS; Faedo C; Barba MA; Dieguez M; de Andrés R; Hernandez AM; Gonzalez-Estrada A; Padró T; Fuentes F; Badimon L; Mata P;
    Lancet Diabetes Endocrinol; 2024 Sep; 12(9):643-652. PubMed ID: 39098315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
    Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study.
    Sánchez-Ramos A; Fernández-Labandera C; Vallejo-Vaz AJ; Bonacho EC; Quevedo-Aguado L; Catalina-Romero C; Valdivielso P; Sánchez-Chaparro MÁ
    Atherosclerosis; 2021 Dec; 338():39-45. PubMed ID: 34785430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study.
    Puddu PE; Lanti M; Menotti A; Mancini M; Zanchetti A; Cirillo M; Angeletti M;
    Acta Cardiol; 2002 Jun; 57(3):177-85. PubMed ID: 12088175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.